Xencor, Inc.
Clinical trials sponsored by Xencor, Inc., explained in plain language.
-
Lung cancer drug combo trial halted early
Disease control TerminatedThis study tested a new drug called vudalimab combined with chemotherapy as a first treatment for people with advanced non-small cell lung cancer. It compared this combination to the standard treatment of pembrolizumab plus chemotherapy. The trial was stopped early after enrollin…
Phase: PHASE1, PHASE2 • Sponsor: Xencor, Inc. • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New drug for skin conditions shows early promise in safety trial
Symptom relief TerminatedThis early-stage study tested a new drug called XmAb27564 in 23 people with plaque psoriasis or atopic dermatitis (eczema). The main goal was to see if the drug is safe and tolerable when given as multiple injections. The study was stopped early, so results are limited.
Phase: PHASE1 • Sponsor: Xencor, Inc. • Aim: Symptom relief
Last updated May 26, 2026 03:18 UTC